NCT03483662Completed
Implementation of Multifaceted Patient-Centered Treatment Strategies for Intensive Blood Pressure Control (IMPACTS)
Dissemination and Implementation of the SPRINT Study Findings in Underserved Populations
Source: ClinicalTrials.gov · Last updated 9 Jul 2025
Brief summary (registry, in English)
The IMPACTS study utilizes an effectiveness-implementation hybrid type 2 design to achieve two primary goals simultaneously: 1). to test the effectiveness of a multifaceted implementation strategy for intensive BP control among underserved hypertensive patients at high risk for CVD, and 2). to assess the implementation outcomes of the multifaceted implementation strategy in patients and providers.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 1272 (actual)
- First submitted
- 24 Mar 2018
- Start date
- 27 Jun 2018
- Primary completion date
- 15 Feb 2024
- Lead sponsor
- Tulane University
- Diseases
- High blood pressure
- NCT number
- NCT03483662
What you commit to
- Study type: Interventional
- Participants enrolled: 1272
- From 27 Jun 2018 to the primary completion date, 15 Feb 2024
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Diagnosis of end-stage renal disease, defined as dialysis or transplantation.
Other
- Not able to understand English
- Pregnant women, women planning to become pregnant in the next 18 months, women of childbearing potential and not practicing birth control, and persons who cannot give informed consent.
- Plans to change to a primary healthcare provider outside of the FQHC clinic during the next 18 months.
- Individuals unlikely to complete the study, such as those who plan to move out the study area during the next 18 months, temporary migrant workers, and homeless persons.
- Patients with immediate family members who are staff at their FQHC clinic.
Who the study is looking for
- Men or women aged ≥40 years who receive primary care from the participating FQHC clinics.
- Systolic BP ≥140 mmHg at two screening visits for those not taking antihypertensive medication or systolic BP ≥ 130 mmHg at two screening visits for those taking antihypertensive medications.
Criteria the registry did not label
- Eligibility Criteria for Clinics:
- Affiliated with participating FQHCs and not sharing providers or nurses/pharmacists with other clinics.
- Predominantly managing underserved populations with health disparities (ethnic minorities, low-income groups, and residents of rural areas and inner cities).
- Having electronic medical record systems.
- Serving \>200 hypertension patients (ICD-10-CM I10-I15) during the previous year.
- Not participating in other hypertension control programs.
Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| 10 FQHC Primary Care Clinics in Mississippi Coordinator of this site? Confirm its status | Biloxi | United States | Unknown status |
| 26 FQHC Primary Care Clinics in Louisiana Coordinator of this site? Confirm its status | New Orleans | United States | Unknown status |
Related publications
- Multifaceted Strategies for Hypertension Control in Low-Income Patients.N Engl J Med · 2026 · PMID 41950472
This page is information, not medical advice. Discuss any trial with your doctor.